These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28699616)

  • 1. Levamisole in Frequently-relapsing and Steroid-dependent Nephrotic Syndrome.
    Kiruba Samuel EM; Krishnamurthy S; Bhanudeep S; Muske S
    Indian Pediatr; 2017 Oct; 54(10):831-834. PubMed ID: 28699616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of mycophenolate mofetil versus levamisole therapy in frequently relapsing and steroid dependent childhood nephrotic syndrome - A retrospective comparative analysis.
    Sharma S; Kalra S; Shukla S; Sharma P
    Nephrology (Carlton); 2022 Sep; 27(9):758-762. PubMed ID: 35619554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome.
    Ekambaram S; Mahalingam V; Nageswaran P; Udani A; Geminiganesan S; Priyadarshini S
    Indian Pediatr; 2014 May; 51(5):371-3. PubMed ID: 24953577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children.
    Basu B; Babu BG; Mahapatra TK
    Clin Exp Nephrol; 2017 Feb; 21(1):143-151. PubMed ID: 27108294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A; Hari P; Moudgil A; Jordan SC
    Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and acceptability of immunosuppressive agents for pediatric frequently-relapsing and steroid-dependent nephrotic syndrome: A network meta-analysis of randomized controlled trials.
    Tan L; Li S; Yang H; Zou Q; Wan J; Li Q
    Medicine (Baltimore); 2019 May; 98(22):e15927. PubMed ID: 31145359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
    Sinha A; Puraswani M; Kalaivani M; Goyal P; Hari P; Bagga A
    Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome.
    Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S
    Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
    BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of levamisole treatment in childhood nephrotic syndrome.
    Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S
    Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
    Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
    BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
    Alsaran K; Grisaru S; Stephens D; Arbus G
    Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open label non-inferiority randomized controlled trial evaluated alternate day prednisolone given daily during infections vs. levamisole in frequently relapsing nephrotic syndrome.
    Sinha A; Devi KG; Kalra S; Mani K; Hari P; Bagga A
    Kidney Int; 2024 May; 105(5):1113-1123. PubMed ID: 38360110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
    Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience.
    Kuźma-Mroczkowska E; Skrzypczyk P; Pańczyk-Tomaszewska M
    Cent Eur J Immunol; 2016; 41(3):243-247. PubMed ID: 27833440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with levamisole in frequently relapsing, steroid-dependent nephrotic syndrome.
    Al-Saran K; Mirza K; Al-Ghanam G; Abdelkarim M
    Pediatr Nephrol; 2006 Feb; 21(2):201-5. PubMed ID: 16222548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.